Adravision Receives FDA Clearance for AI-driven Dental Image Enhancement Technology

USA: Adravision marks a major milestone with the acquisition of 510(k) clearance from the U.S. Food & Drug Administration (FDA) for its Adravision Perio product. This regulatory approval opens the gateway for Adravision to introduce its AI-driven dental image enhancement technology into dental practices.

Ensuring Reliability and Compliance

The FDA clearance not only marks a triumph for Adravision but also assures dental practitioners and patients of the technology’s reliability and compliance with regulatory standards. Established in 2021, Adravision stands as part of YCombinator’s health technology portfolio and the Advanced Technology Development Center at Georgia Tech.

AI-Driven Dentistry: Catalyst for Enhanced Patient Care and Confidence

AI Technology for Enhanced Periodontal Assessment

Adravision’s Software as a Medical Device (SaMD) utilizes real-time AI to assist dentists and hygienists in evaluating mesial and distal bone levels in bitewing and periapical radiographs. According to Hamed Fesharaki (BDS), Adravision’s CEO, the AI-driven technology offers high accuracy in highlighting bone loss. Fesharaki emphasizes the technology’s significance in facilitating the diagnosis and treatment planning of periodontal disease, affecting over 45% of U.S. adults.

Addressing Periodontitis for Comprehensive Health

The untreated progression of periodontitis can lead to severe consequences, including tooth loss, impaired chewing, and associations with heart disease and arthritis. The American Academy of Periodontology estimates the economic impact of untreated periodontal disease on the U.S. economy at approximately $154 billion.

FDA clears first AI-powered radiologic detection aid

Streamlining Patient Care and Insurance Processes

Adravision Perio not only enhances patient comprehension of oral issues, leading to increased treatment acceptance rates, but also streamlines the claims process for insurers, reducing the potential for fraud. Dr. Fesharaki highlights the company’s mission to empower dental professionals, emphasizing the shared goal of delivering effective and high-quality patient care.

Adravision’s Innovative Approach

Adravision, represented by adra.ai, embodies an innovative platform that brings together the expertise of scientists, dental practitioners, and AI professionals. The robust Software as a Service (SaaS) tools offered by Adravision aim to revolutionize the interpretation of dental radiographs. The platform’s goal is to empower dental practitioners, allowing them to streamline workflow, reduce time spent on interpretations, and ultimately deliver superior patient care.